Tag: in vitro diagnostics market share

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

In Vitro Diagnostics Market Expansion Outlook: What Revenue Opportunities Are Ahead?

The in vitro diagnostics market size has seen rapid expansion in recent years. It is forecast to increase from $136.55 billion in 2025 to $152.42 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. The historical surge in this market can be attributed to several factors including an expansion in diagnostic testing volumes, an increase in infectious disease screening, the rising prevalence of chronic conditions, enhancements in laboratory infrastructure, and improved access to healthcare.

The in vitro diagnostics market is projected to experience substantial expansion in the coming years. It is anticipated to reach $241.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2%. This growth during the projected period can be attributed to factors such as the increasing embrace of decentralized diagnostics, growing investments in molecular testing technologies, the expansion of personalized medicine diagnostics, a heightened demand for rapid and precise testing, and the increasing incorporation of AI-driven diagnostics. Key trends observed within the forecast timeframe encompass the increasing prevalence of point-of-care diagnostic devices, a surge in demand for molecular and immunoassay testing, the expanding utilization of automated laboratory systems, the broadening of multiplex diagnostic platforms, and an intensified emphasis on rapid testing solutions.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=45307383&type=smp&name=In%20Vitro%20Diagnostics%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In Vitro Diagnostics Market Growth Catalysts And Demand Drivers

The in vitro diagnostics market is expected to expand due to the rising incidence of cancer, which comprises a diverse range of over 100 diseases capable of emerging in various locations throughout the body. This upward trend in cancer prevalence is linked to lifestyle modifications, including increased tobacco use, poor diet, physical inactivity, and environmental pollution, collectively heightening cancer risk across populations. In vitro diagnostics (IVDs) represent a category of tests or medical devices that analyze samples extracted from the human body, furnishing crucial information for the screening, diagnosis, and treatment of cancer. For instance, in January 2023, according to the National Center for Biotechnology Information, a US-based intergovernmental organization, the United States was projected to have 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Therefore, the increasing prevalence of cancer is anticipated to propel the growth of the in vitro diagnostics market.

In Vitro Diagnostics Market Segment Trends And Revenue Contributors

The in vitro diagnostics market covered in this report is segmented –

1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

In Vitro Diagnostics Market Trends Shaping Long-Term Demand

Major companies engaged in the in vitro diagnostics market are integrating advanced technologies such as UIMG image technology and a 2D decoder chip to elevate the precision and efficiency of diagnostic tests, improve data analysis, streamline workflow processes, and ultimately achieve better patient outcomes. UIMG image technology is an advanced imaging technique employed in diagnostics to capture and analyze high-resolution images, thereby enhancing the visualization and interpretation of biological samples. For instance, in November 2023, Newland, an EMEA, Netherlands-based technology company, introduced its IVD (in vitro diagnostics) product line. This new IVD product line features five barcode scanners that are compact, robust, and designed for automated diagnostic processes. These scanners are intended to boost the speed and accuracy of diagnostics, which is essential given the growing demand for efficient healthcare solutions.

In Vitro Diagnostics Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

View The Full In Vitro Diagnostics Market Report:

https://thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

In Vitro Diagnostics Market Geographic Landscape: Which Region Leads Industry Growth?

North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Much Larger Will The In Vitro Diagnostics Market Become By 2030 Compared To 2026?

The in vitro diagnostics market size has experienced significant growth in recent years. It is anticipated to increase from $136.55 billion in 2025 to $152.42 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.6%. This historical expansion can be attributed to several factors, including the increased volume of diagnostic testing, a rise in infectious disease screening, the escalating prevalence of chronic conditions, enhancements in laboratory infrastructure, and broader access to healthcare services.

The in vitro diagnostics market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $241.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. This growth during the forecast period is fueled by factors such as the greater adoption of decentralized diagnostics, escalating investments in molecular testing technologies, the broadening scope of personalized medicine diagnostics, a heightened demand for swift and precise testing, and the increasing incorporation of AI-driven diagnostic solutions. Key trends anticipated within this period encompass the wider embrace of point-of-care diagnostic devices, an escalating need for molecular and immunoassay testing, the expanding utilization of automated laboratory systems, the development of multiplex diagnostic platforms, and a reinforced emphasis on quick testing methods.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What Are The Main Drivers Accelerating The Growth Of The In Vitro Diagnostics Market?

The rising incidence of cancer is projected to stimulate the expansion of the in vitro diagnostics market. Cancer itself is a broad category covering over 100 distinct diseases that can manifest in various parts of the body. This increase in cancer prevalence is attributed to shifts in lifestyle, such as greater tobacco use, unhealthy diets, lack of physical activity, and environmental pollution, which collectively heighten cancer risk among individuals. In vitro diagnostics (IVDs) are medical tests or devices that examine samples taken from the human body, supplying critical information for the screening, diagnosis, and treatment of cancer. For example, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, indicated that the United States is expected to see 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Thus, the growing prevalence of cancer is set to propel the in vitro diagnostics market forward.

What Segment Types Are Included In The In Vitro Diagnostics Market Analysis?

The in vitro diagnostics market covered in this report is segmented –

1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Which Trends Are Guiding The Development Of The In Vitro Diagnostics Market?

Key players in the in vitro diagnostics market are adopting advanced technologies like UIMG image technology and a 2D decoder chip to elevate the accuracy and efficiency of diagnostic tests, improve data analysis, streamline workflow processes, and ultimately achieve better patient outcomes. UIMG image technology is an advanced imaging method utilized in diagnostics to capture and analyze high-resolution images, thereby improving the visualization and interpretation of biological samples. For example, in November 2023, Newland, an EMEA, Netherlands-based technology company, launched its IVD (in vitro diagnostics) product line. This new IVD product line features five barcode scanners that are compact, rugged, and optimized for automated diagnostic processes. These scanners are intended to enhance the speed and accuracy of diagnostics, which is crucial given the increasing demand for efficient healthcare solutions.

Which Industry Players Are Present In The In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Access The Complete In Vitro Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Region Commands The Largest Share Of The In Vitro Diagnostics Market?

North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a In Vitro Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2026, By The Business Research Company

In Vitro Diagnostics Ivd Quality Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

In Vitro Diagnostics Enzymes Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The In Vitro Diagnostics Market From 2026 To 2030?

The in vitro diagnostics market has witnessed substantial growth over recent years. Its valuation is projected to rise from $136.55 billion in 2025 to $152.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. This historical expansion can be primarily linked to an increase in diagnostic testing volumes, more extensive screening for infectious diseases, the escalating burden of chronic illnesses, advancements in laboratory infrastructure, and improved access to healthcare.

The in vitro diagnostics market is set to experience swift expansion in the upcoming years. It is forecast to reach $241.14 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.2%. This projected increase can be attributed to the rising adoption of decentralized diagnostics, increased investments in molecular testing technologies, the broadening of personalized medicine diagnostics, a surging demand for rapid and accurate testing, and the expanding integration of ai-driven diagnostics. Notable trends during this period encompass the greater embrace of point-of-care diagnostic devices, an elevated demand for molecular and immunoassay testing, the increasing utilization of automated laboratory systems, the proliferation of multiplex diagnostic platforms, and an intensified focus on rapid testing.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What Significant Factors Are Influencing The In Vitro Diagnostics Market Expansion?

The rising prevalence of cancer is expected to significantly drive the expansion of the in vitro diagnostics market. Cancer refers to a wide array of over 100 distinct diseases that can develop in numerous locations throughout the body. The increasing occurrence of cancer can be attributed to evolving lifestyle choices, including heightened tobacco use, insufficient diet, physical inactivity, and environmental pollution, factors that collectively increase cancer risk across populations. In vitro diagnostics (IVDs) encompass a category of tests or medical devices that examine samples taken from the human body, providing essential information for the screening, diagnosis, and treatment of cancer. For instance, in January 2023, according to the National Center for Biotechnology Information, a US-based intergovernmental organization, the United States is projected to experience 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Therefore, the expanding incidence of cancer is anticipated to fuel the growth of the in vitro diagnostics market.

What Are The Main Segments Within The In Vitro Diagnostics Market Segment Structure?

The in vitro diagnostics market covered in this report is segmented –

1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

What Trends Are Affecting The Direction Of The In Vitro Diagnostics Market?

Leading companies in the in vitro diagnostics market are embracing advanced technologies, such as UIMG image technology and 2D decoder chips, to elevate the precision and efficiency of diagnostic tests, refine data analysis, streamline operational procedures, and ultimately achieve superior patient outcomes. UIMG image technology is a sophisticated imaging technique utilized in diagnostics for capturing and analyzing high-resolution images, thereby improving the visualization and interpretation of biological samples. For example, in November 2023, Newland, an EMEA, Netherlands-based technology company, unveiled its IVD (in vitro diagnostics) product line. This new IVD product line features five barcode scanners that are compact, robust, and optimized for automated diagnostic processes. These scanners are designed to enhance the speed and accuracy of diagnostics, which is essential given the rising demand for efficient healthcare solutions.

Who Are The Companies Participating In The In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Get The Full In Vitro Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Region Leads The In Vitro Diagnostics Market In Terms Of Market Share?

North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized In Vitro Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2026, By The Business Research Company

In Vitro Diagnostics Ivd Quality Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

In Vitro Diagnostics Enzymes Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The In Vitro Diagnostics Market In 2026 And What Value Is Projected For 2030?

The in vitro diagnostics market has experienced rapid growth in its size over recent years. It is anticipated to expand from $136.55 billion in 2025 to $152.42 billion in 2026, at a compound annual growth rate (CAGR) of 11.6%. The historical growth can be attributed to factors such as an expansion in diagnostic testing volumes, an increase in infectious disease screening, the rising prevalence of chronic diseases, advancements in laboratory infrastructure, and broader healthcare access.

The in vitro diagnostics market is projected for swift expansion over the coming years. This market is anticipated to reach $241.14 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 12.2%. Factors contributing to this growth during the forecast period include the increasing embrace of decentralized diagnostics, greater investments in molecular testing technologies, the broadening of personalized medicine diagnostics, an escalating need for quick and precise testing, and the rising incorporation of AI-driven diagnostics. Key trends anticipated for the forecast period encompass a wider acceptance of point-of-care diagnostic devices, an escalating requirement for molecular and immunoassay testing, the increasing deployment of automated laboratory systems, the proliferation of multiplex diagnostic platforms, and a heightened emphasis on swift testing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What Key Drivers Are Influencing The Growth Of The In Vitro Diagnostics Market?

The rising incidence of cancer is anticipated to drive the expansion of the in vitro diagnostics market. Cancer itself is a diverse group of over 100 diseases that can manifest in various parts of the body. This increasing prevalence of cancer is attributable to shifts in lifestyle, including heightened tobacco consumption, inadequate dietary practices, a lack of physical activity, and environmental pollution, which collectively elevate cancer risk across populations. In vitro diagnostics (IVDs) encompass a category of tests or medical devices that analyze samples taken from the human body, delivering critical information for the screening, diagnosis, and treatment of cancer. For instance, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, reported that the United States was projected to have 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Thus, the escalating prevalence of cancer is expected to fuel the growth of the in vitro diagnostics market.

What Are The Key Segments Of The In Vitro Diagnostics Market?

The in vitro diagnostics market covered in this report is segmented –

1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

What Key Trends Are Influencing The Development Of The In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market are integrating advanced technologies, such as UIMG image technology and a 2D decoder chip, to elevate the precision and effectiveness of diagnostic tests, refine data analysis, optimize workflow processes, and ultimately achieve better patient outcomes. UIMG image technology specifically functions as an advanced imaging method in diagnostics, designed to capture and analyze high-resolution images, thereby enhancing the visualization and interpretation of biological samples. For example, in November 2023, Newland, an EMEA, Netherlands-based technology company, introduced its IVD (in vitro diagnostics) product line. This new IVD product range consists of five barcode scanners that are compact, robust, and specifically designed for automated diagnostic processes. These scanners aim to improve the speed and accuracy of diagnostics, which is particularly vital given the increasing need for efficient healthcare solutions.

Who Are The Leading Companies Operating In The In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Read the full in vitro diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Region Is Expected To Register The Fastest Growth In The In Vitro Diagnostics Market?

North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored In Vitro Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2026, By The Business Research Company

In Vitro Diagnostics Ivd Quality Control Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

In Vitro Toxicology Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

In Vitro Diagnostics Enzymes Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the In Vitro Diagnostics Market from 2026 to 2030?

The in vitro diagnostics market size has seen rapid expansion in recent years. It is anticipated to increase from $136.55 billion in 2025 to $152.42 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. The historical growth of this market can be attributed to factors such as the expansion of diagnostic testing volumes, an increase in infectious disease screening, the growing burden of chronic diseases, enhancements in laboratory infrastructure, and broader healthcare access.

The in vitro diagnostics market is anticipated to undergo significant growth in the upcoming years. It is predicted to expand to $241.14 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.2%. This expansion during the forecast period can be attributed to the increasing adoption of decentralized diagnostics, rising investments in molecular testing technologies, the proliferation of personalized medicine diagnostics, a growing demand for rapid and accurate testing, and the increasing integration of AI-driven diagnostics. Prominent trends for this period include the wider adoption of point-of-care diagnostic devices, an escalating demand for molecular and immunoassay testing, the increasing use of automated laboratory systems, the expansion of multiplex diagnostic platforms, and an intensified focus on rapid testing.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What Drivers Are Affecting Demand In The In Vitro Diagnostics Market?

The rising incidence of cancer is predicted to drive expansion within the in vitro diagnostics market. Cancer refers to a wide array of more than 100 distinct diseases that can develop in different parts of the body. This increasing prevalence stems from lifestyle modifications such as elevated tobacco consumption, inadequate nutrition, lack of physical activity, and environmental contaminants, all of which jointly elevate the risk of cancer among populations. In vitro diagnostics (IVDs) are a type of test or medical apparatus used to examine human body samples, providing vital data for the screening, diagnosis, and management of cancer. For example, in January 2023, the National Center for Biotechnology Information, a US-based intergovernmental organization, reported that the United States was projected to experience 1,958,310 new cancer cases and 609,820 cancer deaths in 2023. Consequently, the growing occurrence of cancer is projected to further stimulate the in vitro diagnostics market’s growth.

Which Segment Groups Are Influencing The In Vitro Diagnostics Market?

The in vitro diagnostics market covered in this report is segmented –

1) By Diagnostic: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By Type of Expenditure: Public, Private

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

What Upcoming Trends Are Likely To Define The Future Path Of The In Vitro Diagnostics Market?

Major companies within the in vitro diagnostics market are integrating advanced technologies such as UIMG image technology and a 2D decoder chip. This adoption aims to enhance the precision and efficiency of diagnostic tests, improve data analysis capabilities, streamline workflow processes, and ultimately deliver superior patient outcomes. UIMG image technology itself is an advanced imaging method utilized in diagnostics to capture and analyze high-resolution images, thereby improving the visualization and interpretation of biological samples. For instance, in November 2023, Newland, an EMEA, Netherlands-based technology company, launched its IVD (in vitro diagnostics) product line. This new line comprises five compact, rugged barcode scanners optimized for automated diagnostic processes. These scanners are designed to improve the speed and accuracy of diagnostics, which is critically important given the increasing demand for efficient healthcare solutions.

Who Are The Top-Performing Companies In The In Vitro Diagnostics Market In Recent Years?

Major companies operating in the in vitro diagnostics market are Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The In Vitro Diagnostics Market?

North America was the largest region in the global in-vitro diagnostics market in 2025. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in vitro diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized In Vitro Diagnostics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2026, By The Business Research Company

In Vitro Diagnostics Ivd Quality Control Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-ivd-quality-control-global-market-report

In Vitro Toxicology Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-toxicology-testing-global-market-report

In Vitro Diagnostics Enzymes Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-enzymes-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the in vitro diagnostics market from 2025–2034 with trusted insights from The Business Research Company

How Much Will The In Vitro Diagnostics Market Be Worth By 2029, And What CAGR Will It Achieve?

The in vitro diagnostics market has experienced rapid expansion in recent years. This market is expected to expand from $121.96 billion in 2024 to reach $136.55 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 12.0%. Factors contributing to its past expansion include the development of automated analyzers and molecular diagnostics, an aging population, instances of disease outbreaks, evolving healthcare regulations, and the progress of personalized medicine.

The in vitro diagnostics market is projected to undergo substantial expansion in the coming years. Its valuation is set to reach $214.88 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 12.0%. This anticipated growth during the forecast period is driven by developments in precision medicine, point-of-care testing, digital health and data analytics, and increased pandemic preparedness. Significant trends expected during this period involve technological advancements, the integration of digital health, personalized diagnostics, the availability of home testing kits, and molecular diagnostics.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

Which Factors Are Driving The In Vitro Diagnostics Market Forward?

The increasing adoption of self-administered test kits is projected to fuel the expansion of the in vitro diagnostics market moving ahead. These kits are defined as medical or diagnostic tools specifically created for personal use, allowing individuals to conduct tests independently at home without the involvement of healthcare professionals or trained staff. Such kits enhance ease of access by empowering people to perform diagnostic assessments from their residences, thereby offering convenience and potentially stimulating greater demand for testing, especially for conditions that have gone unnoticed. A notable instance illustrating this trend occurred in April 2022, where the Centers for Disease Control and Prevention, a US-based national public health agency, reported a substantial increase in at-home COVID-19 test utilization among U.S. adults aged 18 and older. This surge was observed from the Delta-predominant period (August to December 2021) to the Omicron-predominant period (December to March 2022). Specifically, the proportion of respondents experiencing COVID-19-like symptoms who opted for at-home tests grew from 5.7% to 20.1%. Consequently, the growing favorability of self-administered test kits will serve as a key driver for the in vitro diagnostics market’s advancement.

Which Segments Form The Key Structure Of The In Vitro Diagnostics Market?

The in vitro diagnosticsmarket covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

How Are Global Trends Impacting The Development Of The In Vitro Diagnostics Market?

Leading firms active in the in vitro diagnostics market are concentrating on creating novel products, like the Cobas pulse system, aiming to boost their market profitability. This Cobas pulse system serves as a specialized blood glucose management solution, incorporating mobile digital health features to enhance patient care. As an example, in January 2022, Roche Diagnostics, a US-based company known for developing innovative products and services covering disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system. The Cobas pulse system itself is a portable instrument outfitted with an automated glucose test strip reader, a camera, and a touchscreen, facilitating the recording of extra diagnostic information. Its intuitive interface is engineered for simple deployment, offering practical functions that optimize processes, conserve time, and improve operational workflows.

Which Firms Are Making The Biggest Impact In The In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Region Is Expected To Lead The In Vitro Diagnostics Market In The Next Few Years?

North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The In Vitro Diagnostics Market From 2025 To 2034?

The global in vitro diagnostics market has experienced substantial expansion lately, projected to increase its valuation from $121.96 billion in the year 2024 to $136.55 billion a year later, reflecting an impressive compound annual growth rate of 12.0% throughout this period; this historic upswing is fundamentally linked to advancements such as the progress in automated analysis systems and molecular diagnostic techniques, coupled with demographic shifts like the aging populace, the emergence of public health crises, evolving healthcare compliance standards, and the increasing adoption of individualized patient treatments.

Forecasting substantial expansion, the in vitro diagnostics sector is projected to achieve a market valuation of $214.88 billion by the year 2029, reflecting a speedy upward trajectory evidenced by a compound annual growth rate (CAGR) of 12.0% throughout this forecast duration, a surge primarily fueled by the increasing adoption of precision medicine approaches, the proliferation of point-of-care testing solutions, advancements in digital health paired with robust data analytics capabilities, and enhanced global pandemic preparedness strategies, while key industry movements shaping this period encompass ongoing technological leaps forward, deeper integration of digital health platforms, a shift towards highly personalized diagnostic methods, a rise in at-home testing kit utilization, and ongoing innovation within molecular diagnostics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What Are The Top Growth Drivers Impacting The In Vitro Diagnostics Market Outlook?

The increasing adoption of testing solutions intended for personal use is anticipated to bolster the expansion of the in vitro diagnostics sector in the near future. These testing kits, meant for individual self-use, are diagnostical tools formulated so that people can conduct the required analysis on themselves, eliminating the necessity for healthcare workers or trained staff to be present during home testing. Such kits improve testing reach by allowing diagnostic procedures to be completed within the comfort of one’s dwelling, thereby providing ease and potentially boosting testing volume, especially concerning ailments that were previously undetected. To illustrate this trend, data released in April 2022 by the Centers for Disease Control and Prevention, a key public health organization in the United States, showed a notable uptick in domestic COVID-19 test usage among American adults aged 18 and above when comparing the period dominated by the Delta variant (spanning August through December 2021) with the phase characterized by the Omicron variant (from December 2021 to March 2022); specifically, among those reporting symptoms similar to COVID-19, the proportion using at-home testing climbed considerably from 5.7% to 20.1%, confirming that the growing preference for self-administered testing mechanisms will serve as a catalyst for the growth trajectory of the in vitro diagnostics market.

What Are The Major Segment Categories Driving The In Vitro Diagnostics Market Growth?

The in vitro diagnosticsmarket covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

What Trends Are Redefining The In Vitro Diagnostics Market Dynamics?

Key players within the in vitro diagnostics sector are heavily invested in creating novel offerings, exemplified by the Cobas pulse system, with the aim of boosting their financial returns in this arena. This Cobas pulse system represents a professional approach to blood glucose management, incorporating mobile digital health features intended to elevate the standard of patient care. To illustrate, in the month of January 2022, Roche Diagnostics, an American entity specializing in creating cutting-edge products and services for disease prevention, detection, ongoing management, screening, and treatment, introduced the Cobas pulse system to the market. This particular Cobas pulse system is a handheld instrument outfitted with technology such as an automated strip reader for glucose testing, an integrated camera, and a touchscreen interface enabling the logging of supplementary diagnostic details. Optimized for simplicity of deployment, its intuitive design incorporates beneficial functionalities engineered to simplify operational procedures, conserve valuable time, and improve overall work efficiency.

Which Industry Leaders Are Driving Innovation Across The In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The In Vitro Diagnostics Market?

North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request A Customized Version Of The In Vitro Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Predicted Market Size Trajectory For The In Vitro Diagnostics Market From 2025 To 2034?

The global in vitro diagnostics market has experienced substantial expansion lately, projected to increase its valuation from $121.96 billion in the year 2024 to $136.55 billion a year later, reflecting an impressive compound annual growth rate of 12.0% throughout this period; this historic upswing is fundamentally linked to advancements such as the progress in automated analysis systems and molecular diagnostic techniques, coupled with demographic shifts like the aging populace, the emergence of public health crises, evolving healthcare compliance standards, and the increasing adoption of individualized patient treatments.

Forecasting substantial expansion, the in vitro diagnostics sector is projected to achieve a market valuation of $214.88 billion by the year 2029, reflecting a speedy upward trajectory evidenced by a compound annual growth rate (CAGR) of 12.0% throughout this forecast duration, a surge primarily fueled by the increasing adoption of precision medicine approaches, the proliferation of point-of-care testing solutions, advancements in digital health paired with robust data analytics capabilities, and enhanced global pandemic preparedness strategies, while key industry movements shaping this period encompass ongoing technological leaps forward, deeper integration of digital health platforms, a shift towards highly personalized diagnostic methods, a rise in at-home testing kit utilization, and ongoing innovation within molecular diagnostics.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What Are The Top Growth Drivers Impacting The In Vitro Diagnostics Market Outlook?

The increasing adoption of testing solutions intended for personal use is anticipated to bolster the expansion of the in vitro diagnostics sector in the near future. These testing kits, meant for individual self-use, are diagnostical tools formulated so that people can conduct the required analysis on themselves, eliminating the necessity for healthcare workers or trained staff to be present during home testing. Such kits improve testing reach by allowing diagnostic procedures to be completed within the comfort of one’s dwelling, thereby providing ease and potentially boosting testing volume, especially concerning ailments that were previously undetected. To illustrate this trend, data released in April 2022 by the Centers for Disease Control and Prevention, a key public health organization in the United States, showed a notable uptick in domestic COVID-19 test usage among American adults aged 18 and above when comparing the period dominated by the Delta variant (spanning August through December 2021) with the phase characterized by the Omicron variant (from December 2021 to March 2022); specifically, among those reporting symptoms similar to COVID-19, the proportion using at-home testing climbed considerably from 5.7% to 20.1%, confirming that the growing preference for self-administered testing mechanisms will serve as a catalyst for the growth trajectory of the in vitro diagnostics market.

What Are The Major Segment Categories Driving The In Vitro Diagnostics Market Growth?

The in vitro diagnosticsmarket covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

What Trends Are Redefining The In Vitro Diagnostics Market Dynamics?

Key players within the in vitro diagnostics sector are heavily invested in creating novel offerings, exemplified by the Cobas pulse system, with the aim of boosting their financial returns in this arena. This Cobas pulse system represents a professional approach to blood glucose management, incorporating mobile digital health features intended to elevate the standard of patient care. To illustrate, in the month of January 2022, Roche Diagnostics, an American entity specializing in creating cutting-edge products and services for disease prevention, detection, ongoing management, screening, and treatment, introduced the Cobas pulse system to the market. This particular Cobas pulse system is a handheld instrument outfitted with technology such as an automated strip reader for glucose testing, an integrated camera, and a touchscreen interface enabling the logging of supplementary diagnostic details. Optimized for simplicity of deployment, its intuitive design incorporates beneficial functionalities engineered to simplify operational procedures, conserve valuable time, and improve overall work efficiency.

Which Industry Leaders Are Driving Innovation Across The In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The In Vitro Diagnostics Market?

North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Request A Customized Version Of The In Vitro Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model